Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LQDA Liquidia Technologies Inc

Post-Market Trading 11-22 16:22:03 EST

10.65

+0.50

+4.93%

盘后10.65

+0.000.00%

16:02 EST

High10.73	Low10.02	Vol1.05M
Open10.15	D1 Closing10.15	Amplitude7.00%
Mkt Cap901.38M	Tradable Cap566.26M	Total Shares84.64M
T/O11.01M	T/O Rate1.97%	Tradable Shares53.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":10.65,"timestamp":1732309200000,"preClose":10.15,"halted":0,"volume":1048545,"hourTrading":{"tag":"盘后","latestPrice":10.65,"preClose":10.65,"latestTime":"16:02 EST","volume":20116,"amount":214247.79145599998,"timestamp":1732309349508},"delay":0,"floatShares":53170401,"shares":84636621,"eps":-1.617348,"marketStatus":"Post-Market Trading","change":0.5,"latestTime":"11-22 16:22:03 EST","open":10.15,"high":10.73,"low":10.02,"amount":11013248.63981,"amplitude":0.069951,"askPrice":10.67,"askSize":1923,"bidPrice":10.07,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.617348,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1732323600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":10.15,"preHourTrading":{"tag":"盘前","latestPrice":10.22,"preClose":10.15,"latestTime":"09:29 EST","volume":1022,"amount":10388.83951,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":10.65,"preClose":10.65,"latestTime":"16:02 EST","volume":20116,"amount":214247.79145599998,"timestamp":1732309349508},"volumeRatio":1.471599,"impliedVol":0.6171,"impliedVolPercentile":0.1151},"requestUrl":"/m/hq/s/LQDA","defaultTab":"news","newsList":[{"id":"2484266219","title":"3 US Growth Stocks With At Least 10% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2484266219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484266219?lang=en_us&edition=fundamental","pubTime":"2024-11-19 23:04","pubTimestamp":1732028677,"startTime":"0","endTime":"0","summary":"As geopolitical tensions rise, the U.S. stock market has experienced early declines, with major indices such as the Dow Jones Industrial Average and S&P 500 slipping amid investor concerns. In this environment of uncertainty, stocks with substantial insider ownership can offer a unique perspective on potential growth opportunities, as insiders may have confidence in their company's long-term prospects despite short-term market fluctuations.Top 10 Growth Companies With High Insider Ownership In The United States. Click here to see the full list of 207 stocks from our Fast Growing US Companies With High Insider Ownership screener.Overview: AudioEye, Inc. offers patented software and services for internet content publication and distribution to ensure accessibility across various devices and locations in the United States, with a market cap of $310.66 million.Overview: Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products for unmet pa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gnGTQ_q9KCdl7Xvx_ppB0g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fe4d5d105492213ce106a92b49639d4","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gnGTQ_q9KCdl7Xvx_ppB0g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0fe4d5d105492213ce106a92b49639d4"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-us-growth-stocks-least-150437463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4229","BK4585","LU2265009873.SGD","BK4023","TBBB","BK4146","BK4195","AEYE","LQDA","BK4588","GHLD","LU1804176565.USD","BK4113","ONON","BK4547"],"gpt_icon":0},{"id":"2483334326","title":"Liquidia Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334326","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483334326?lang=en_us&edition=fundamental","pubTime":"2024-11-15 18:59","pubTimestamp":1731668346,"startTime":"0","endTime":"0","summary":"NasdaqCM:LQDA Earnings and Revenue History November 15th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 6.2%. Earnings per share  also surpassed analyst estimates by 20%.Looking ahead, revenue is forecast to grow 60% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in the US.The company's shares are down 7.4% from a week ago.Be aware that  Liquidia is showing  2 warning signs in our investment analysis that you should know about...","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liquidia-third-quarter-2024-earnings-105906991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LQDA"],"gpt_icon":0},{"id":"2483467874","title":"Liquidia Technologies (LQDA) Gets a Buy from Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2483467874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483467874?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:37","pubTimestamp":1731587823,"startTime":"0","endTime":"0","summary":"Scotiabank analyst Greg Harrison maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) today and set a price target of $30.00. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/liquidia-technologies-lqda-gets-a-buy-from-scotiabank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/liquidia-technologies-lqda-gets-a-buy-from-scotiabank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2483606826","title":"Liquidia Price Target Maintained With a $19.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2483606826","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483606826?lang=en_us&edition=fundamental","pubTime":"2024-11-14 17:50","pubTimestamp":1731577800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LQDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 04:50 ET (09:50 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"gpt_icon":0},{"id":"2483848130","title":"Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483848130","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483848130?lang=en_us&edition=fundamental","pubTime":"2024-11-14 15:09","pubTimestamp":1731568140,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Liquidia Corp  has a clear path to seeking final approval for Reia, with potential approval as early as May 2025.The company has successfully expanded its relationship with Hermosa, securing rights for L 606 in the EU and other territories outside North America.The clinical progress of Reia and L 606 is promising, with positive preliminary data from the Ascent study showing good tolerability and titratability.The company has a well-prepared sales force with significant experience in rare diseases, ready to launch Reia upon FDA approval.Research and development expenses have increased significantly, up 60% from the previous year, impacting the company's financials.The company faces ongoing litigation challenges, including a lawsuit against the FDA and a patent dispute with United Therapeutics.GuruFocus has detected 5 Warning Signs with LQDA.A:  We have been engaging with payers since rece","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/y7uv9tF0e9VfnuivZKaf_g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d49bd1affdb5cee18ae454108dc3b421","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/y7uv9tF0e9VfnuivZKaf_g--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d49bd1affdb5cee18ae454108dc3b421"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liquidia-corp-lqda-q3-2024-070900748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LQDA"],"gpt_icon":0},{"id":"2483880384","title":"Liquidia Corp reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880384","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483880384?lang=en_us&edition=fundamental","pubTime":"2024-11-13 23:25","pubTimestamp":1731511543,"startTime":"0","endTime":"0","summary":"* Liquidia Corp    reported a quarterly adjusted loss of 30 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -24 cents.  The ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"gpt_icon":0},{"id":"2483885240","title":"Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483885240","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483885240?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:40","pubTimestamp":1731501603,"startTime":"0","endTime":"0","summary":"Liquidia Technologies, Inc.  came out with a quarterly loss of $0.37 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.35 per share when it actually produced a loss of $0.37, delivering a surprise of -5.71%.Liquidia Technologies , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $4.45 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.75%. This compares to year-ago revenues of $3.68 million. The company has topped consensus revenue estimates just once over the last four quarters.Liquidia Technologies shares have lost about 11.6% since the beginning of the year versus the S&P 500's gain of 25.5%.While Liquidia Technologies has underperformed the market so far this year, the question that comes to investors' minds is: what's next f","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6Ex_CnpNXcMseRWMhPXBow--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6Ex_CnpNXcMseRWMhPXBow--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liquidia-technologies-inc-lqda-reports-124003135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LQDA"],"gpt_icon":0},{"id":"2483904008","title":"Liquidia Q3 2024 GAAP EPS $(0.30) Beats $(0.37) Estimate, Sales $4.45M Beat $4.19M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483904008","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483904008?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:31","pubTimestamp":1731497482,"startTime":"0","endTime":"0","summary":"Liquidia (NASDAQ:LQDA) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by 18.92 percent. This is a 25 percent decrease over losses of $(0.24) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41934195/liquidia-q3-2024-gaap-eps-0-30-beats-0-37-estimate-sales-4-45m-beat-4-19m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Liquidia Q3 2024 GAAP EPS $(0.30) Beats $(0.37) Estimate, Sales $4.45M Beat $4.19M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"gpt_icon":0},{"id":"2483008653","title":"Liquidia Q3 Revenue USD 4.448 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483008653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483008653?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:30","pubTimestamp":1731497400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nPLX3D58A9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2483700866","title":"Liquidia Q3 Basic EPS USD -0.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2483700866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483700866?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:30","pubTimestamp":1731497400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nPLX3D58A9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LQDA","BK4007"],"gpt_icon":0},{"id":"2483038620","title":"Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483038620","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483038620?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:30","pubTimestamp":1731497400,"startTime":"0","endTime":"0","summary":"Received tentative approval from the FDA for YUTREPIA (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/13/2980056/0/en/Liquidia-Corporation-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","LU0208291251.USD","LU0417517546.SGD","LU0320765489.SGD","LU1699723380.USD","BK4161","BK4585","BK4580","LU1989772840.SGD","UTHR","BK4532","LU1571399168.USD","LU0256863811.USD","BK4007","PH","BK4202","LU0211331839.USD","LU0256863902.USD","LU1989772923.USD","LU0070302665.USD","NCI","LQDA"],"gpt_icon":1},{"id":"2483488077","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2483488077","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483488077?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:00","pubTimestamp":1731495600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JD","DTI","KORE","CINT","ASND","LQDA","UGP","MIST","MCRB","BLRX","EXAI","DGII","GAMB","CREX","IVVD","SHCO","LVLU","CPRT","MURA","BEEM","HAYN","BN","DNMR","GOEV","ICAD","KRMD","EC","ENLT","HBM","DFLI","SONO","AMAT","CIG","BOXL","DMAC","AFCG","INO","BRAG","GLOB","INKT","KMDA","ADAP","BRFS","BZH","SLRN","HI","SLE","INVZ","CELC"],"gpt_icon":1},{"id":"2482333701","title":"Liquidia to Present at the Stifel 2024 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2482333701","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482333701?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:00","pubTimestamp":1731416400,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Nov. 12, 2024  -- Liquidia Corporation , a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present at the Stifel 2024 Healthcare Conference in New York City on Tuesday, November 19, 2024, from 3:00 – 3:30 p.m. ET.An archived, recorded version of each presentation will be available on Liquidia’s website for at least 30 days following the event.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Y4LIE2IBWZfUsy_EFpZoPg--~B/aD05Njt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d042c1b1bbb8357374c79bb205d10a5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Y4LIE2IBWZfUsy_EFpZoPg--~B/aD05Njt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d042c1b1bbb8357374c79bb205d10a5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liquidia-present-stifel-2024-healthcare-130000915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4127","BK4137","HCSG","SF","LQDA"],"gpt_icon":1},{"id":"2482823644","title":"Liquidia Corp    expected to post a loss of 37 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482823644","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482823644?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:59","pubTimestamp":1731085161,"startTime":"0","endTime":"0","summary":"* Liquidia Corp     is expected to show a rise in quarterly revenue when it reports  results on November 13 for the period ending September 30 2024   * The Morrisville North Carolina-based  company is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Liquidia Corp    expected to post a loss of 37 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"gpt_icon":0},{"id":"2481490739","title":"Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?","url":"https://stock-news.laohu8.com/highlight/detail?id=2481490739","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481490739?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:27","pubTimestamp":1730978820,"startTime":"0","endTime":"0","summary":"Arcellx, Inc.  shares rallied 6.7% in the last trading session to close at $92.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7.8% gain over the past four weeks.The sudden rise in the stock price can be attributed to the positive investor mindset regarding the potential of Arcellx’s clinical-stage oncology pipeline. The company is currently evaluating several candidates in separate clinical studies across various stages of development for several oncology indications like multiple myeloma, acute myeloid leukemia and myelodysplastic syndrome.This company is expected to post quarterly loss of $0.54 per share in its upcoming report, which represents a year-over-year change of +33.3%. Revenues are expected to be $35.21 million, up 135.3% from the year-ago quarter.Arcellx belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Liquidia Techn","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/iI5piNm2vFo3HCLgtvsz_w--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9bb0f7469abe2b88d816d427f27fa1ed","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/iI5piNm2vFo3HCLgtvsz_w--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9bb0f7469abe2b88d816d427f27fa1ed"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcellx-aclx-stock-jumps-6-112700551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LQDA","ACLX","BK4007","BK4139"],"gpt_icon":0},{"id":"2481197177","title":"Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2481197177","media":"Simply Wall St.","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481197177?lang=en_us&edition=fundamental","pubTime":"2024-11-07 18:49","pubTimestamp":1730976586,"startTime":"0","endTime":"0","summary":"When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can see its share price rise well over 100%. For example, the Liquidia Corporation  share price has soared 186% in the last half decade. Most would be very happy with that. The last week saw the share price soften some 3.4%.Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.For the last half decade, Liquidia can boast revenue growth at a rate of 27% per year. Even measured against other revenue-focussed companies, that's a good result. So it's not entirely surprising that the share price reflected this performance by increasing at a rate of 23% per year, in that time. So it seems likely that buyers have paid attention to the strong revenue growth. To our minds that makes Liquidia worth investigating - it may have its best days ahead.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-liquidia-nasdaq-lqda-seen-104946890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","ISBC","IE00BGHQF748.EUR","LQDA","BK4588","QID","LU2210149790.SGD","SQQQ","BK4007","LU2210150020.SGD","BK4112","MNQmain",".IXIC","NDAQ","LU2095319765.USD","BK4211","IE00BKPKM429.USD","NQmain","QLD","TQQQ","IE00B64PRP62.GBP","PSQ","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2481051606","title":"Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481051606","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481051606?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:00","pubTimestamp":1730898000,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Nov.  06, 2024  (GLOBE NEWSWIRE) -- Liquidia Corporation(NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/06/2975659/0/en/Liquidia-Corporation-to-Report-Third-Quarter-2024-Financial-Results-on-November-13-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA"],"gpt_icon":1},{"id":"2480001053","title":"Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2480001053","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480001053?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:00","pubTimestamp":1730725200,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Nov. 04, 2024  -- Liquidia Corporation, a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2024 financial results on Monday, November 11, 2024. The company will host a live webcast at8:30 a.m. Eastern Timeto discuss its financial results and provide a corporate update.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Y4LIE2IBWZfUsy_EFpZoPg--~B/aD05Njt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d042c1b1bbb8357374c79bb205d10a5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Y4LIE2IBWZfUsy_EFpZoPg--~B/aD05Njt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/6d042c1b1bbb8357374c79bb205d10a5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liquidia-corporation-report-third-quarter-130000213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LQDA"],"gpt_icon":1},{"id":"2480283526","title":"Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2480283526","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480283526?lang=en_us&edition=fundamental","pubTime":"2024-11-01 22:00","pubTimestamp":1730469620,"startTime":"0","endTime":"0","summary":"The market expects Y-mAbs Therapeutics, Inc.  to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 8. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This company is expected to post quarterly loss of $0.12 per share in its upcoming report, which represents a year-over-year change of +33.3%.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/I67vygGrP1BjgOjVx.apeA--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/y-mabs-therapeutics-inc-ymab-140020243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LQDA","YMAB"],"gpt_icon":0},{"id":"2479335482","title":"Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2479335482","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479335482?lang=en_us&edition=fundamental","pubTime":"2024-10-29 22:01","pubTimestamp":1730210469,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year decline in earnings on higher revenues when Liquidia Technologies, Inc.  reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This company is expected to post quarterly loss of $0.37 per share in its upcoming report, which represents a year-over-year change of -54.2%.Revenues are expected to be $4.42 million, up 20.1% from t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wXNaNKXxuWlbebD.cUCv9g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wXNaNKXxuWlbebD.cUCv9g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liquidia-technologies-inc-lqda-expected-140109261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LQDA","CSTL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":0.0125},{"period":"1month","weight":-0.0937},{"period":"3month","weight":0.0181},{"period":"6month","weight":-0.1828},{"period":"1year","weight":0.5104},{"period":"ytd","weight":-0.1563}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.035484},{"month":2,"riseRate":0.833333,"avgChangeRate":0.087008},{"month":3,"riseRate":0.5,"avgChangeRate":-0.044367},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.075222},{"month":5,"riseRate":0.833333,"avgChangeRate":0.15291},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.059983},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.087113},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.013548},{"month":9,"riseRate":0.428571,"avgChangeRate":0.082402},{"month":10,"riseRate":0.571429,"avgChangeRate":0.019418},{"month":11,"riseRate":0.571429,"avgChangeRate":0.018673},{"month":12,"riseRate":0.666667,"avgChangeRate":0.188565}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction